Recurrent Miscarriage and IVF in North Cyprus: How PGT-A Improves Outcomes

Understanding Recurrent Miscarriage

Recurrent miscarriage, defined as two or more consecutive pregnancy losses, affects approximately 1-2% of couples trying to conceive. The emotional toll is devastating, and many couples feel helpless after repeated losses. However, modern reproductive medicine now offers powerful solutions. IVF treatment combined with preimplantation genetic testing (PGT-A) in North Cyprus has become a highly effective pathway for couples facing this challenge.

The most common causes of recurrent miscarriage include chromosomal abnormalities in the embryo, which account for 50-60% of all cases. Other contributing factors are uterine anomalies such as septate uterus or fibroids, immunological disorders including antiphospholipid syndrome, thrombophilia conditions like Factor V Leiden, and hormonal imbalances.

How PGT-A Addresses Chromosomal Causes

The Role of Genetic Screening

PGT-A allows embryologists to screen embryos for chromosomal abnormalities before transfer. By analyzing all 23 pairs of chromosomes, clinics can identify euploid (chromosomally normal) embryos and transfer only those with the highest chance of successful implantation and ongoing pregnancy. Studies show that PGT-A reduces miscarriage rates from approximately 30% down to 10-15% in patients with a history of recurrent loss.

Treatment Protocol in North Cyprus

The treatment begins with ovarian stimulation and egg retrieval, followed by ICSI fertilization. Embryos are cultured to the blastocyst stage (day 5-6), and a trophectoderm biopsy is performed. Results are typically available within 7-14 days, during which embryos are safely vitrified. Only genetically healthy embryos are selected for frozen embryo transfer.

Beyond Genetics: Comprehensive Testing

North Cyprus fertility clinics also investigate immunological and hematological factors. Treatments may include low-dose aspirin, heparin therapy for thrombophilia, intralipid infusions for elevated natural killer cells, and progesterone support protocols. This multi-faceted approach addresses all potential causes simultaneously.

Costs and Success Rates

An IVF cycle with PGT-A in North Cyprus typically costs between $5,000 and $8,000, representing savings of 40-60% compared to Western Europe or the US. Success rates for patients with recurrent miscarriage who use PGT-A screened embryos reach 55-65% per transfer. Experienced fertility consultants can guide you through personalized treatment plans designed to overcome recurrent pregnancy loss and achieve the healthy pregnancy you deserve.